Citation Impact
Citing Papers
Risk Factors for Venous Thromboembolism
2003 Standout
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
2015 Standout
Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregation
1976 StandoutNobel
Treatment of deep vein thrombosis with streptokinase.
1975
A Novel Subtype of the Prostacyclin Receptor Expressed in the Central Nervous System
1996 StandoutNobel
Heparin-Protein Interactions
2002 Standout
Streptokinase therapy for deep vein thrombosis: A comprehensive review of the english literature
1990
Hydrogels in Regenerative Medicine
2009 Standout
Human Fibrinogen
1988
Prevention of Venous Thromboembolism in General Surgical Patients
1988
Antithrombotic Therapy for VTE Disease
2016 Standout
Hyaluronan: from extracellular glue to pericellular cue
2004 Standout
In Vitro Effects of Different Medium Molecular Hydroxyethyl Starch Solutions and Lactated Ringer’s Solution on Coagulation Using SONOCLOT
2000
Subcutaneous Low-Molecular-Weight Heparin Compared with Continuous Intravenous Heparin in the Treatment of Proximal-Vein Thrombosis
1992 Standout
Effects of extracellular matrix viscoelasticity on cellular behaviour
2020 StandoutNature
The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome
1995 Standout
The Coagulopathy of Trauma: A Review of Mechanisms
2008
Hydroxyethyl starches and dextran during hip replacement surgery: effects on blood volume and coagulation
2011 StandoutNobel
Very Low Doses of Warfarin Can Prevent Thrombosis in Central Venous Catheters
1990
Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth
1997 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Factors affecting .gamma.-chain multimer formation in crosslinked fibrin
1992
Fabrication and physical and biological properties of fibrin gel derived from human plasma
2007
Prevention of VTE in Nonorthopedic Surgical Patients
2012 Standout
Nonlinear elasticity in biological gels
2005 StandoutNature
Prevention of Venous Thromboembolism
2004 Standout
In vitro and in vivo evaluation of chemically modified degradable starch microspheres for topical haemostasis
2011 StandoutNobel
Fibrin in human plasma: Gel architectures governed by rate and nature of fibrinogen activation
1994
Acute Pancreatitis
1994 Standout
Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma
1994 Standout
Prevention of Venous Thromboembolism
2008 Standout
Thrombin generation, fibrin clot formation and hemostasis
2008
Fibrin network structure and clot mechanical properties are altered by incorporation of erythrocytes
2009
Guidelines for the Prevention of Intravascular Catheter-related Infections
2011 Standout
Human plasma fibrinogen measurement derived from activated partial thromboplastin time clot formation
2002
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Use of the Gottingen Minipig as a Model of Diabetes, with Special Focus on Type 1 Diabetes Research
2004
Mesenchymal Stem Cell-Mediated Functional Tooth Regeneration in Swine
2006 Standout
Comparison of surface plasmon resonance and quartz crystal microbalance in the study of whole blood and plasma coagulation
2000 StandoutNobel
Conformation of one- and two-chain high molecular weight urokinase analyzed by small-angle neutron scattering and vacuum ultraviolet circular dichroism
1991 StandoutNobel
Interactions of Prostaglandin H2 and Thromboxane A2 with Human Serum Albumin
1980 StandoutNobel
Maturation of the hemostatic system during childhood
1992 Standout
The role of blood flow in platelet adhesion, fibrin deposition, and formation of mural thrombi
1973
No Effect of Clot Age or Thrombolysis on Argatroban’s Inhibition of Thrombin
1998
Quantitative characterization of the binding of plasminogen to intact fibrin clots, lysine-Sepharose, and fibrin cleaved by plasmin
1985
Small Subcutaneous Doses of Heparin in Prevention of Venous Thrombosis
1973
The incidence of deep vein thrombosis in Hong Kong Chinese after hip surgery for fracture of the proximal femur
1979
Molecular Physiology of P2X Receptors
2002 Standout
Prevention of Venous Thromboembolism
1981
Growth Rate in vivo of Platelet Thrombi, produced by Iontophoresis of ADP, as a Function of Mean Blood Flow Velocity
1970 Nature
Is Embolic Risk Conditioned By Location of Deep Venous Thrombosis?
1981
Factors contributing to increased vascular fibrinolytic activity in mongrel dogs.
1993
HUMAN ARTERIAL AND VENOUS TISSUES GENERATE PROSTACYCLIN (PROSTAGLANDIN X), A POTENT INHIBITOR OF PLATELET AGGREGATION
1977 StandoutNobel
Human primary fibroblasts in vitro express a purinergic P2X7 receptor coupled to ion fluxes, microvesicle formation and IL-6 release
1999
The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial
2011 Standout
Hyaluronan stimulates tumor cell migration by modulating the fibrin fiber architecture
1999
Renal actions of prostacyclin
1978 StandoutNatureNobel
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
The Complex Effects of Heparins on Cancer Progression and Metastasis in Experimental Studies
2001
COMPARISON OF THE VASODEPRESSOR EFFECTS OF PROSTACYCLIN AND 6‐OXO‐PROSTAGLANDIN F1α WITH THOSE OF PROSTAGLANDIN E2 IN RATS AND RABBITS
1978 StandoutNobel
Self-Assembled Organic Monolayers: Model Systems for Studying Adsorption of Proteins at Aurfaces
1991 StandoutScience
Role of Prostacyclin in the Cardiovascular Response to Thromboxane A 2
2002 StandoutScience
Chronic Thromboembolic Pulmonary Hypertension
2006 Standout
Characterization of an Extremely Large, Ligand-Induced Conformational Change in Plasminogen
1990 StandoutScienceNobel
Effect of Dextran on Factor VIII (Antihemophilic Factor) and Platelet Function
1979
Guidelines for Adult Stroke Rehabilitation and Recovery
2016 Standout
DOES T4 TOXICOSIS EXIST ?
1975
Pancreatic ischaemia in experimental acute pancreatitis: Mechanism, significance and therapy
1990
The Epidemiology of Venous Thromboembolism
2003 Standout
SOME DIRECT AND REFLEX CARDIOVASCULAR ACTIONS OF PROSTACYCLIN (PGI2) AND PROSTAGLANDIN E2 IN ANAESTHETIZED DOGS
1980 StandoutNobel
A Prospective Study of Streptokinase and Heparin in the Treatment of Deep Vein Thrombosis
1978
Thrombectomy with temporary arteriovenous fistula: The treatment of choice in acute iliofemoral venous thrombosis
1984
Thrombectomy with temporary arteriovenous fistula: The treatment of choice in acute iliofemoral venous thrombosis
1984
Prophylaxis of postoperative venous thrombosis in a controlled trial comparing dextran 70 and low‐dose heparin
1980
NMR Assignment and Secondary Structure Determination of an Octameric 110 kDa Protein Using TROSY in Triple Resonance Experiments
2000 StandoutNobel
Prostaglandins and Thromboxanes
1978 StandoutNobel
The Pathogenesis of Atherosclerosis
1976 Standout
Albumin modulates lateral assembly of fibrin polymers: evidence of enhanced fine fibril formation and of unique synergism with fibrinogen
1987
Development of a Point of Care Lateral Flow Device for Measuring Human Plasma Fibrinogen
2010 StandoutNobel
Argatroban Anticoagulant Therapy in Patients With Heparin-Induced Thrombocytopenia
2001 Standout
In Vitro Effects of Different Medium Molecular Hydroxyethyl Starch Solutions and Lactated Ringer’s Solution on Coagulation Using SONOCLOT
2000
PROSTACYCLIN (PGI2) INHIBITS THE FORMATION OF PLATELET THROMBI IN ARTERIOLES AND VENULES OF THE HAMSTER CHEEK POUCH
1978 StandoutNobel
The vasodilatation induced by hydroperoxy metabolites of arachidonic acid in the rat mesenteric and pulmonary circulation
1987 StandoutNobel
The role of fragment X polymers in the fibrin enhancement of tissue plasminogen activator-catalyzed plasmin formation.
1990 StandoutNobel
Works of D.P. Dhall being referenced
Dextran 70 in Prophylaxis of Postoperative Venous Thrombosis. A Controlled Trial
1970
Studies on fibrin network structure: The effect of some plasma proteins
1991
Studies on fibrin network structure in human plasma. Part one: Methods for clinical application
1991
Interaction of endothelial cells and fibroblasts with modified fibrin networks: role in atherosclerosis
1997
Colloid determination of fibrin network permeability
1996
Comparison of fibrin networks in plasma and fibrinogen solution
1987
PERIPHERAL VENOUS SCANNING WITH 125I-TAGGED FIBRINOGEN
1972
Physiological studies on fibrin network structure
1985
Effect of temperature, ph and ionic strength and composition on fibrin network structure and its development
1986
Fibrin Network Structure: Modification by Platelets
1983
VENOUS THROMBOSIS IN AFRICANS
1975
Prophylaxis in iliofemoral venous thrombosis the major amputee as a clinical research model
1973
Streptokinase therapy in deep-vein thrombosis
1973
Biolaser Endothelial Trauma as a Means of Quantifying Platelet Activity in vivo
1968 Nature
Dextrans and Fibrin Morphology
1972 Nature
The significance of red cell surface area to the permeability of fibrin network
1994
Counteraction of Platelet Activity at Sites of Laser-induced Endothelial Trauma
1968
Studies on Fibrin Formation and Effects of Dextran
1972
Polydispersion in the diameter of fibers in fibrin networks: Consequences on the measurement of mass–length ratio by permeability and turbidity
1982
EFFECTS OF DEXTRAN INFUSION ON THE ADHESIVENESS OF HUMAN BLOOD-PLATELETS
1966
On the binding of native plasminogen to fibrin and its role in thrombolysis
1983
INDUCTION AND MANAGEMENT OF DIABETES MELLITUS IN THE PIG
1986
Effects of Dextran on the Molecular Structure and Tensile Behaviour of Human Fibrin
1976